Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spark licenses blindness gene therapy rights outside U.S. to Novartis
Spark licenses blindness gene therapy rights outside U.S. to Novartis
Spark licenses blindness gene therapy rights outside U.S. to Novartis
Submitted by
admin
on January 25, 2018 - 12:00am
Source:
Yahoo/Reuters
News Tags:
Spark Therapeutics
Novartis
Luxturna
gene therapy
Headline:
Spark licenses blindness gene therapy rights outside U.S. to Novartis
Do Not Allow Advertisers to Use My Personal information
